This communication reports on the Mycetoma Research Centre of the University of Khartoum,
Sudan experience on 6,792 patients seen during the period 1991–2014.The patients were …

Patients with mycetoma usually present late with advanced disease, which is attributed to
lack of medical and health facilities in endemic areas, poor health education and low socio-…

Background Antimicrobial resistance (AMR) poses a complex threat to global health security
and universal health coverage. Recently, nosocomial infections with carbapenemase-…

Clinical details are tabulated. Most patients presented with unilateral proptosis of varying
severity, the duration of symptoms being from 4 months to 10 yr. Cultures of biopsy specimens …

Treatment of mycetoma depends on the causative organism and since many organisms,
both actinomycetes (actinomycetoma) and fungi (eumycetoma), are capable of producing …

A new species of nonsporulating fungus, isolated in a case of black-grain mycetoma in
Sudan, is described as Madurella fahalii . The species is characterized by phenotypic and …

A number of drugs and drug combinations were tested both in vitro and in vivo against pathogens
causing actinomycetoma and maduromycetoma. Of 144 patients with actinomycetoma …

Mycetoma is a unique neglected tropical disease which is endemic in what is known as the “mycetoma
belt”. The disease has many devastating impacts on patients and communities in …

Background Antimicrobial resistance (AMR) among Gram-negative bacilli is a global health
problem. Surveillance of AMR is required to advise on empirical antimicrobial therapy. This …

Lymphatic spread of mycetoma agents to regional lymph nodes with consequent enlargement
is reported in 13 cases. 9 of these were due to Streptomyces somaliensis, 3 Madurella …